This study was funded by the Instituto de Salud Carlos III (ISCIII) through the project PI23/01205 and cofunded by the European Union
We cannot rule out that the risk of certain subtypes of thyroid cancer is increased in smaller patient groups that we could not study here, for example in people with a high congenital risk of medullary thyroid cancer who are advised against using these drugs, says Peter Ueda, assistant professor at the Department of Medicine, Solna, at Karolinska Institutet
Schedule an Appointment Today Resources Dharmarajan, Thiruvinvamalai S., S
Your vial says milligrams (mg), your syringe says units (U) or milliliters (ml), and suddenly it feels like a math test
The Role of Surgery in the new era of targeted therapies for anaplastic thyroid cancer
A Data-Driven Plan is Non-Negotiable : GLP-1s can be a powerful alternative to traditional treatments like Metformin, but the right choice depends on your unique biology